Home / News & Insights / Whistleblower Law Insights / Bayer AG is the latest pharma company to acknowledge it is being investigated by Chinese authorities for its marketing and sales practices in China

Bayer AG is the latest pharma company to acknowledge it is being investigated by Chinese authorities for its marketing and sales practices in China

Given the growing number of pharma companies in China under investigation for bribery and corruption, it’s becoming more a question of who isn’t being investigated, rather than who is.
Pharma companies currently under investigation by Chinese authorities include:
  •   Bayer AG
  • GlaxoSmithKline
  • Novo Nordisk A/S
  • Sanofi SA
  • Eli Lilly
  • Sino Biopharmaceuticals
  • AstraZeneca
  • UCB
Bayer gets a quarter of its global revenue from the Asia-Pacific region, according to Reuters.
Let us help you.
Get a free, confidential case review